Wounds Clinical Trial
Official title:
Double-Blind, Randomized, Placebo-Controlled Phase 2 Study to Investigate the Safety and Efficacy of 0.1% and 1.0% Topically Applied GLYC-101, Compared to Placebo, in Patients Undergoing Carbon Dioxide Laser Skin Resurfacing of the Lower Eyelids.
Verified date | October 2021 |
Source | TR Therapeutics |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary objectives of this study are to evaluate safety and efficacy of topically applied Glucoprime gel (GLYC-101, 0.1% and GLYC-101, 1.0%) in promoting wound healing in cosmetic surgery patients undergoing Carbon Dioxide Laser Skin Resurfacing (CO2 LSR) of the lower eyelids. The study will observe the effects of the topical agent over the course of 1 month following the initial treatment.
Status | Completed |
Enrollment | 26 |
Est. completion date | January 2010 |
Est. primary completion date | January 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 25 Years to 70 Years |
Eligibility | Inclusion Criteria: - Male and female healthy volunteer subjects, between 25 and 70 years of age, giving informed consent for facial laser ablation of the lower eyelid areas for the purpose of wrinkle removal. - Lower eyelid skin is free of any irritation, scarring or dermatologic conditions which might interfere with the study. - Willing and able to participate in the study and follow all study directions. - Able to read, understand and sign the consent form prior to any study related procedures. Exclusion Criteria: - Female subjects who are pregnant, nursing, or planning a pregnancy during the course of the study, as determined by the interview and a urine pregnancy test. - Presence of irritation or dermatologic skin conditions in the lower eyelid area. - Known allergies to materials within the test formulations (i.e., yeast and/or yeast products). - Use of topical or systemic drugs (corticosteroids, retinoids, immune modulators, immune suppressants, drugs with potential for contact dermatitis, drugs with potential for skin discoloration) that may have an effect on wound healing or may impact skin pigmentation. - A history, upon wounding, of developing thickened scars, keloids, or excessive pigment change. - An unstable or severe inter-current medical condition that, in the opinion of the investigator, might interfere with interpretation of study results or render the subject at high risk for treatment complications. - Use of any investigational medication or device for any indication within 30 days of screening. |
Country | Name | City | State |
---|---|---|---|
United States | CLINICAL TESTING CENTER of BEVERLY HILLS | Beverly Hills | California |
Lead Sponsor | Collaborator |
---|---|
TR Therapeutics |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to Complete Wound Closure (Epithelialization) | Subjects were evaluated daily from the time of the laser procedure and initial application of test article until the subject's wounds reached 100% epithelialization. Efficacy was assessed based on the time to complete epithelialization in terms of the number of days from Day 1 (day of laser ablation) to the day on which complete epithelialization was observed. | Over the course of 1 month following the initial treatment. | |
Secondary | Cosmesis/11-point Likert Scale | The cosmetic effect on each lower eyelid using an 11-point Likert Scale (0 = not healed and 10 = healed). | At 1 month following the initial treatment. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02865902 -
Low-level Laser Therapy in Enhancing Wound Healing and Preserving Tissue Thickness
|
N/A | |
Terminated |
NCT01191567 -
Negative Pressure Wound Therapy. Therapy Effects and the Impact on the Patient's Quality of Life
|
N/A | |
Completed |
NCT01227759 -
Tyrosur® Gel-Investigation on Wound Healing Efficacy
|
Phase 2 | |
Recruiting |
NCT00737425 -
Safety and Efficacy Study of Pain Shield Device to Treat Subjects Following Laparoscopic-Assisted Abdominal Surgery
|
Phase 4 | |
Terminated |
NCT00762138 -
The AutoloGelâ„¢ Post-Market Surveillance (TAPS) Program
|
N/A | |
Completed |
NCT00746109 -
Study of Wound Packing After Superficial Skin Abscess Drainage
|
Phase 4 | |
Withdrawn |
NCT00234559 -
Trial of Vacuum Assisted Closure® Therapy Versus Control Therapy in Angiogenesis
|
N/A | |
Not yet recruiting |
NCT03872544 -
Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
|
||
Enrolling by invitation |
NCT03880188 -
Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
|
||
Recruiting |
NCT05588583 -
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
|
N/A | |
Completed |
NCT02591537 -
OxyGenesys Dissolved Oxygen Dressing; Abdominoplasty at Northwestern University
|
N/A | |
Recruiting |
NCT05608317 -
A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing
|
N/A | |
Recruiting |
NCT02195063 -
Survey Study for Pain Management, Wound Care, Scar Care or UDT
|
Phase 4 | |
Completed |
NCT01319149 -
A Study of the Effects of Molecular Diagnostic Directed Wound Gels on Wound Care Outcomes
|
N/A | |
Completed |
NCT00153452 -
Workplace Productivity of Persons Who Use Controlling Behavior With Intimate Partners
|
N/A | |
Completed |
NCT06083740 -
A Postmarket Clinical Follow Up Study (PMCF) to Evaluate the Safety and Performance of VERIFORTE/Granudacyn® Med Wound Irrigation Solution.
|
||
Not yet recruiting |
NCT02672280 -
Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02314416 -
Stem Cells In Wound Healing With Collagen Matrix as a Carrier
|
Phase 4 | |
Recruiting |
NCT01454167 -
Acid Base and Electrolytes Patterns in Drains Operational Wounds and Its Relation to Complications
|
N/A | |
Completed |
NCT01921725 -
The Clinical Application and Efficacy Verification of an Innovative Carbon Fiber Dressing
|
N/A |